304 related articles for article (PubMed ID: 33940185)
1. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.
Cucchiara F; Petrini I; Romei C; Crucitta S; Lucchesi M; Valleggi S; Scavone C; Capuano A; De Liperi A; Chella A; Danesi R; Del Re M
Pharmacol Res; 2021 Jul; 169():105643. PubMed ID: 33940185
[TBL] [Abstract][Full Text] [Related]
2. Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
Chen K; He Y; Wang W; Yuan X; Carbone DP; Yang F
Sci Bull (Beijing); 2024 May; 69(10):1556-1568. PubMed ID: 38641511
[TBL] [Abstract][Full Text] [Related]
3. [Study Progress of Radiomics in Precision Medicine for Lung Cancer].
Shi Z; Zhang X; Jiang T
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):385-388. PubMed ID: 31196373
[TBL] [Abstract][Full Text] [Related]
4. Radiomics and artificial intelligence for precision medicine in lung cancer treatment.
Chen M; Copley SJ; Viola P; Lu H; Aboagye EO
Semin Cancer Biol; 2023 Aug; 93():97-113. PubMed ID: 37211292
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
Lococo F; Boldrini L; Diepriye CD; Evangelista J; Nero C; Flamini S; Minucci A; De Paolis E; Vita E; Cesario A; Annunziata S; Calcagni ML; Chiappetta M; Cancellieri A; Larici AR; Cicchetti G; Troost EGC; Ádány R; Farré N; Öztürk E; Van Doorne D; Leoncini F; Urbani A; Trisolini R; Bria E; Giordano A; Rindi G; Sala E; Tortora G; Valentini V; Boccia S; Margaritora S; Scambia G
BMC Cancer; 2023 Jun; 23(1):540. PubMed ID: 37312079
[TBL] [Abstract][Full Text] [Related]
6. Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring.
Kroschke J; von Stackelberg O; Heußel CP; Wielpütz MO; Kauczor HU
Rofo; 2022 Jul; 194(7):720-727. PubMed ID: 35211928
[TBL] [Abstract][Full Text] [Related]
7. Radiomics and liquid biopsy in oncology: the holons of systems medicine.
Neri E; Del Re M; Paiar F; Erba P; Cocuzza P; Regge D; Danesi R
Insights Imaging; 2018 Dec; 9(6):915-924. PubMed ID: 30430428
[TBL] [Abstract][Full Text] [Related]
8. Integration of artificial intelligence in lung cancer: Rise of the machine.
Ladbury C; Amini A; Govindarajan A; Mambetsariev I; Raz DJ; Massarelli E; Williams T; Rodin A; Salgia R
Cell Rep Med; 2023 Feb; 4(2):100933. PubMed ID: 36738739
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
10. Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions.
Zhu W; Love K; Gray SW; Raz DJ
Clin Lung Cancer; 2023 May; 24(3):209-217. PubMed ID: 36797152
[TBL] [Abstract][Full Text] [Related]
11. Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.
Voigt W; Manegold C; Pilz L; Wu YL; Müllauer L; Pirker R; Filipits M; Niklinski J; Petruzelka L; Prosch H
Curr Opin Oncol; 2020 Jan; 32(1):68-77. PubMed ID: 31714259
[TBL] [Abstract][Full Text] [Related]
12. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer.
Shi L; He Y; Yuan Z; Benedict S; Valicenti R; Qiu J; Rong Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782788. PubMed ID: 29940810
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Role of Radiomics in COPD and Lung Cancer.
Refaee T; Wu G; Ibrahim A; Halilaj I; Leijenaar RTH; Rogers W; Gietema HA; Hendriks LEL; Lambin P; Woodruff HC
Respiration; 2020; 99(2):99-107. PubMed ID: 31991420
[TBL] [Abstract][Full Text] [Related]
14. Application of Radiomics and Artificial Intelligence for Lung Cancer Precision Medicine.
Tunali I; Gillies RJ; Schabath MB
Cold Spring Harb Perspect Med; 2021 Aug; 11(8):. PubMed ID: 33431509
[TBL] [Abstract][Full Text] [Related]
15. Radiomics with artificial intelligence for precision medicine in radiation therapy.
Arimura H; Soufi M; Kamezawa H; Ninomiya K; Yamada M
J Radiat Res; 2019 Jan; 60(1):150-157. PubMed ID: 30247662
[TBL] [Abstract][Full Text] [Related]
16. Imaging of Precision Therapy for Lung Cancer: Current State of the Art.
Park H; Sholl LM; Hatabu H; Awad MM; Nishino M
Radiology; 2019 Oct; 293(1):15-29. PubMed ID: 31385753
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
Bennett CW; Berchem G; Kim YJ; El-Khoury V
Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
[TBL] [Abstract][Full Text] [Related]
18. Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy.
Cellina M; De Padova G; Caldarelli N; Libri D; Cè M; Martinenghi C; Alì M; Papa S; Carrafiello G
Crit Rev Oncog; 2024; 29(2):1-13. PubMed ID: 38505877
[TBL] [Abstract][Full Text] [Related]
19. EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Pavlovic M; Boljevic I; Rakobradovic J; Mihajlovic M; Tanic M; Damjanovic A; Malisic E; Jankovic R
J BUON; 2020; 25(6):2635-2642. PubMed ID: 33455107
[TBL] [Abstract][Full Text] [Related]
20. Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype.
Fornacon-Wood I; Faivre-Finn C; O'Connor JPB; Price GJ
Lung Cancer; 2020 Aug; 146():197-208. PubMed ID: 32563015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
